E-LIB Suche - Ergebnisse für: Liranso, Tesfaye

1

Impact of Viloxazine Extended-Release Capsules (Qelbree®) o..:

Wang, Zhao ; Liranso, Tesfaye ; Maldonado-Cruz, Zulane..
Clinical Drug Investigation. 44 (2024) 5 - p. 303-317 , 2024

Link: https://doi.org/10.1007/..

2

Effects of Viloxazine ER (Qelbree®) on Weight and Height Tr..:

Nasser, Azmi ; Hull, Joseph ; Earnest, Jami...
CNS Spectrums. 28 (2023) 2 - p. 218-218 , 2023

Link: https://doi.org/10.1017/..

3

Authors' Reply to Singh and Balasundaram: Comment on "A Pha..:

Nasser, Azmi ; Hull, Joseph T. ; Liranso, Tesfaye...
CNS Drugs. 36 (2022) 12 - p. 1333-1335 , 2022

Link: https://doi.org/10.1007/..

4

A Phase III, Randomized, Double-Blind, Placebo-Controlled T..:

Nasser, Azmi ; Hull, Joseph T. ; Chaturvedi, Soumya A....
CNS Drugs. 36 (2022) 8 - p. 897-915 , 2022

Link: https://doi.org/10.1007/..

5

Evaluating the likelihood to be helped or harmed after trea..:

Nasser, Azmi ; Kosheleff, Alisa R. ; Hull, Joseph T....
International Journal of Clinical Practice. 75 (2021) 8 - p. , 2021

Link: https://doi.org/10.1111/..

6

Impact of a High-Fat Meal and Sprinkled Administration on t..:

Wang, Zhao ; Kosheleff, Alisa R ; Adeojo, Lilian W...
European Journal of Drug Metabolism and Pharmacokinetics. 47 (2021) 1 - p. 69-79 , 2021

Link: https://doi.org/10.1007/..

7

The Effect of Viloxazine Extended-Release Capsules on Funct..:

Nasser, Azmi ; Hull, Joseph T ; Liranso, Tesfaye...
Neuropsychiatric Disease and Treatment. 17 (2021) - p. 1751-1762 , 2021

Link: https://doi.org/10.2147/..

8

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD ..:

Nasser, Azmi ; Liranso, Tesfaye ; Adewole, Toyin...
Clinical Therapeutics. 43 (2021) 4 - p. 684-700 , 2021

Link: https://doi.org/10.1016/..

9

A Double-Blind, Randomized Study of Extended-Release Molind..:

Ceresoli-Borroni, Gianpiera ; Nasser, Azmi ; Adewole, Toyin...
Journal of Attention Disorders. 25 (2020) 11 - p. 1564-1577 , 2020

Link: https://doi.org/10.1177/..

10

114 An Assessment of QTc Effects With SPN-812 (Extended-Rel..:

Nasser, Azmi ; Faison, Shamia L. ; Liranso, Tesfaye...
CNS Spectrums. 25 (2020) 2 - p. 274-274 , 2020

Link: https://doi.org/10.1017/..

11

A Phase III, Randomized, Placebo-controlled Trial to Assess..:

Nasser, Azmi ; Liranso, Tesfaye ; Adewole, Toyin...
Clinical Therapeutics. 42 (2020) 8 - p. 1452-1466 , 2020

Link: https://doi.org/10.1016/..

12

111 Phase 3, Randomized, Double-Blind, Placebo-Controlled S..:

Nasser, Azmi ; Hull, Joseph T. ; Chowdhry, Fatima A....
CNS Spectrums. 25 (2020) 2 - p. 272-272 , 2020

Link: https://doi.org/10.1017/..

13

112 A Phase 3, Randomized, Double-Blind, Placebo-Controlled..:

Nasser, Azmi ; Hull, Joseph T. ; Chowdhry, Fatima A....
CNS Spectrums. 25 (2020) 2 - p. 272-273 , 2020

Link: https://doi.org/10.1017/..

14

113 Phase 3, Randomized, Double-Blind, Placebo-Controlled S..:

Nasser, Azmi ; Hull, Joseph T. ; Chowdhry, Fatima A....
CNS Spectrums. 25 (2020) 2 - p. 273-274 , 2020

Link: https://doi.org/10.1017/..

15

9 Phase 3 Randomized, Double-blind, Placebo-Controlled Stud..:

Nasser, Azmi ; Johnson, Janet K. ; Adewole, Toyin..
CNS Spectrums. 24 (2019) 1 - p. 177-178 , 2019

Link: https://doi.org/10.1017/..